Dreman Value Management’s Usana Health Sciences USNA Stock Holding History

Dreman Value Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$35K	Hold	411	–	–	0.02%	327
2017 Q4	$30K	Hold	411	–	–	0.02%	333
2017 Q3	$24K	Hold	411	–	–	0.01%	318
2017 Q2	$26K	Buy	+411	New	+$25.3K	0.01%	314

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dreman Value Management's USNA Position: Q1 2018 in Review

Dreman Value Management held its Usana Health Sciences (USNA) position steady in Q1 2018 at 411 shares worth $35K. The position accounts for 0.02% of the portfolio, ranked #327.

Dreman Value Management first reported a position in USNA in Q2 2017 and has held it in 4 quarters since. 168 funds tracked by Wall St. Rank hold USNA as of Q1 2018.

Dreman Value Management held 411 shares of Usana Health Sciences worth $35K as of Q1 2018.
Dreman Value Management left its Usana Health Sciences share count unchanged in Q1 2018.
Usana Health Sciences made up 0.02% of Dreman Value Management's portfolio in Q1 2018, its #327 holding.
Dreman Value Management first reported a position in Usana Health Sciences in Q2 2017 and has held it in 4 quarters since.
168 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.